Filter
1622
Filtered Results: 1622
Text search:
parasites
Featured
Recommendations
142
New Publications
393
Language
Document type
No document type
677
Studies & Reports
362
Guidelines
218
Manuals
92
Fact sheets
80
Strategic & Response Plan
54
Resource Platforms
43
Training Material
35
Infographics
18
Videos
15
Brochures
13
Situation Updates
7
Dashboards/Maps
6
Online Courses
2
Countries / Regions
Global
116
India
77
Latin America and the Carribbean
46
Kenya
37
Uganda
33
Africa
31
Senegal
30
Tanzania
30
Ethiopia
29
Nigeria
26
Sierra Leone
25
Mozambique
23
Nepal
22
South Africa
22
Ghana
20
Rwanda
19
Burkina Faso
19
Indonesia
18
Malawi
17
Congo, Democratic Republic of
17
Myanmar / Burma
17
Cameroon
14
Haiti
14
Bangladesh
14
Brazil
14
Philippines
13
Zambia
13
Benin
12
Venezuela
12
South–East Asia Region
12
Colombia
11
Germany
11
Liberia
11
Peru
9
Zimbabwe
9
Cambodia
8
West and Central Africa
8
Western and Central Europe
8
Botswana
7
Madagascar
7
Middle East and North Africa
6
Asia
5
Paraguay
5
Vietnam
5
Namibia
5
South Sudan
5
Guinea
4
East and Southern Africa
4
Bolivia
4
Argentina
4
Angola
4
Ukraine
3
El Salvador
3
Albania
3
USA
3
Dominican Republic
3
North America
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Russia
3
Sudan
3
Honduras
3
Ecuador
3
Eswatini/ Swaziland
3
Pakistan
3
Mexico
2
Lesotho
2
Chile
2
Iran
2
Laos
2
Jordan
2
Eastern Europe and Central Asia
2
Lebanon
2
Eastern Europe
2
Mali
2
Chad
2
Iraq
2
Somalia
2
Cuba
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Turkey
1
China
1
Syria
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Morocco
1
Qatar
1
Bulgaria
1
Italy
1
Saudi Arabia
1
Gabon
1
Uruguay
1
France
1
Mauritius
1
Tunisia
1
Spain
1
Nicaragua
1
Sri Lanka
1
Greece
1
Georgia
1
Central African Republic
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
624
Clinical Guidelines
193
Public Health
104
Key Resources
101
Women & Child Health
53
Pharmacy & Technologies
49
Capacity Building
32
Toolboxes
NTDs
372
AMR
124
Planetary Health
86
Rapid Response
34
COVID-19
33
HIV
30
Caregiver
29
Malaria
28
Pharmacy
26
Global Health Education
24
Mental Health
22
Refugee
21
Ebola & Marburg
21
Natural Hazards
15
TB
14
NCDs
11
Conflict
10
Zika
9
Cholera
6
Social Ethics
5
Health Financing Toolbox
5
Specific Hazards
3
Disability
2
Polio
2
Ce rapport présente les principaux résultats de l’Enquête sur les Indicateurs du Paludisme réalisée au Burkina Faso, de novembre 2017 à mars 2018 (EIPBF 2017-18).
March 2021
This report presents the key findings of the NFHS-5 survey in Sikkim, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and ...
This activity book has been designed, written and illustrated to bring children and young people closer to the world of plant protection; the science that deals with plant health. Although addressed to an age group between eight and twelve years, this book can also be useful for older kids and educa...
It is against this background that the Ministry of Health and Sanitation with its partners have
taken the lead to develop Essential Health Services Package (EHSP). The MOHS believes that the
development of EHSP; defining the services that should be available at each level of care
(community to ...
Con esta guía de referencia rápida podrán reconocer con facilidad las enfermedades y efectos secundarios relacionados con el cambio climático, administrar los tratamientos adecuados y aconsejar a las poblaciones expuestas, presentar información actualizada sobre la relación entre los efectos s...
April 2021
This report presents the key findings of the NFHS-5 survey in Assam, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and e...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But ...
Towards universal access
2nd edition
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of ...
Lancet Infectious Diseases Volume 22, Issue 11e327-e335.
In February, 2022, WHO published new guidelines with six recommendations to update the global public health strategy against schistosomiasis, including expansion of preventive chemotherapy eligibility from the predominant group of school-age...
Au Sénégal, la LAV repose principalement sur deux interventions majeures: la promotion de l’utilisation des Moustiquaires Imprégnées d’Insecticide à longue durée d’Action (MILDA) et l’Aspersion Intra Domiciliaire d’insecticide à effet rémanent (AID). Même si ces deux interventions...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
